 |
From Genome Sequencing to Regulatory Circuits and from Traditional to Network Medicine. omega replica watches www.omegachat.me
|
|
|
|
59-67 |
|
|
Computational Biology, Quantitative Genetics and International Consortiums. |
|
|
|
68-72 |
|
|
Gastric cancer: Practice, Targeted Advances and novel genomics therapeutic approaches. |
|
|
|
73 -78 |
|
|
miRNAs gene expression regulation and their role in cancer prediction and therapy.
|
|
|
|
79-84 |
|
|
New GWAS new hope for disease-risk prediction, prevention, and therapy. |
|
|
|
85-90 |
|
|
Aggressiveness and Complexity of Pancreatic Cancer: Research focused on tumorigenesis-based prevention or metastasis-based treatment? |
|
|
|
91-93 |
|
|
Cetuximab limitations and renew interest in surgical resection and research advances for improving stage IV colorectal cancer outcome. |
|
|
|
94-96 |
|
|
MicroRNAs: A new class of therapeutic targets in cancer |
|
|
|
97-99 |
|
|
Family history and BRCA testing change surgery for breast cancer in the USA. |
|
|
|
100-102 |
|
|
Genotyping vs. exome sequencing for cancer. |
|
|
|
103-105 |
|
|
Advances and challenges for laparoscopic rectal cancer surgery. |
|
|
|
106-108 |
|
|
Sequencing Cancer Genome shapes new ways in surgical oncology. |
|
|
|
109-115 |
|
|
Cancer prevention and prophylactic surgery: Standards and GWAS-based perspectives. |
|
|
|
116-122 |
|
|
Breast cancer biomarker: Advances, validation and novel discoveries. |
|
|
|
113-130 |
|
